All stock lists
Unlock the score
Hepion Pharmaceuticals, Inc. (HEPA)
United States · Delayed Price · Currency is USD
Healthcare
0.13+0.00 (-2.96%)
Insider Score
Insider Score
/ 100
HEPA Insider Score
Hepion Pharmaceuticals, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
HEPA analyst forecast
Best analysts covering HEPA
No firm covering HEPA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HEPA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Brookline Capital | Hold | — | — | Downgraded | 2023-12-07 |
| Cantor Fitzgerald | Overweight | $3.50 | -85.8% | Reiterated | 2022-02-28 | |
| — | Brookline Capital | Buy | — | — | Reiterated | 2019-11-22 |
| — | Maxim Group | Hold | — | — | Downgraded | 2019-03-20 |
| — | Maxim Group | Buy | — | — | Upgraded | 2018-07-10 |
| — | Maxim Group | Buy | — | — | Reiterated | 2016-05-06 |
HEPA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-14 | -200.00 | -0.07 | $0 | $0 |
| 2026-08-13 | -200.00 | -0.08 | $0 | $0 |
| 2026-10-26 | -200.00 | 0.00 | $0 | $0 |
| 2027-03-03 | -190.00 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.